Overview
This protocol outlines the process of ex vivo infection of fresh tissue specimens with oncolytic vaccinia virus to assess their infectability. The method includes tissue viability assessment and monitoring of viral replication through gene expression and titer determination.
Key Study Components
Area of Science
- Oncolytic virus therapy
- Cancer therapeutics
- Viral quantification
Background
- Oncolytic viruses are emerging as a promising treatment for cancer.
- Assessing the infectability of patient-derived tissues can guide therapeutic decisions.
- This study focuses on the vaccinia virus as a model for oncolytic therapy.
- Understanding tissue response to viral infection is crucial for treatment efficacy.
Purpose of Study
- To evaluate the ability of fresh surgical tissue to support vaccinia virus replication.
- To identify patient tissues that may respond well to oncolytic virus treatment.
- To provide a methodology for assessing viral infectability in tumor tissues.
Methods Used
- Collection of fresh tissue samples using a biopsy punch.
- Assessment of tissue viability using Alamar Blue assay.
- Infection of tissue samples with GFP and luciferase expressing vaccinia viruses.
- Monitoring viral replication through fluorescence and bioluminescence imaging.
Main Results
- Successful replication of vaccinia virus was observed in the tissue samples.
- Fluorescent protein expression indicated productive viral infection.
- Increased viral titers were measured over time post-infection.
- The method can be adapted for other oncolytic viruses.
Conclusions
- This protocol provides a reliable method for assessing the infectability of tumor tissues.
- Results can inform patient selection for oncolytic virus therapies.
- Further studies may expand the applicability to other viral therapies.
What is the main goal of this protocol?
The main goal is to assess the infectability of fresh surgical tissues with oncolytic vaccinia virus.
How is tissue viability assessed?
Tissue viability is assessed using the Alamar Blue assay before infection.
What types of viruses can this method be applied to?
This method can be adapted for other oncolytic viruses like vesicular stomatitis virus and herpes simplex virus.
What are the implications of this research?
The research can help identify patients who may benefit from oncolytic virus therapies.
What imaging techniques are used to monitor viral replication?
Fluorescence and bioluminescence imaging techniques are used to monitor viral replication in tissues.
What challenges might researchers face when using this method?
Researchers may struggle with obtaining reproducible tissue cores and cutting them into even pieces.
繁體中文
